...
首页> 外文期刊>Biomacromolecules >Surface-Modified P(HEMA-co-MAA) Nanogel Carriers for Oral Vaccine Delivery: Design, Characterization, and In Vitro Targeting Evaluation
【24h】

Surface-Modified P(HEMA-co-MAA) Nanogel Carriers for Oral Vaccine Delivery: Design, Characterization, and In Vitro Targeting Evaluation

机译:用于口服疫苗的表面修饰的P(HEMA-co-MAA)纳米凝胶载体:设计,表征和体外靶向评估

获取原文
获取原文并翻译 | 示例

摘要

Oral drug delivery is a route of choice for vaccine administration because of its noninvasive nature and thus efforts have focused on efficient delivery of vaccine antigens to mucosal sites. An effective oral vaccine delivery system must protect the antigen from degradation upon mucosal delivery, penetrate mucosal barriers, and control the release of the antigen and costimulatory and immunomodulatory agents to specific immune cells (i.e., APCs). In this paper, marinan-modified pH-responsive P(HEMA-co-MAA) nanogels were synthesized and assessed as carriers for oral vaccination. The nanogels showed pH-sensitive properties, entrapping and protecting the loaded cargo at low pH values, and triggered protein release after switching to intestinal pH values. Surface decoration with mannan as carbohydrate moieties resulted in enhanced internalization by macrophages as well as increasing the expression of relevant costimulatory molecules. These findings indicate that mannan-rnodified P(HEMA-co-MAA) nanogels are a promising approach to a more efficacious oral vaccination regimen.
机译:口服药物递送由于其无创性而成为疫苗施用的选择途径,因此努力集中于将疫苗抗原有效递送至粘膜部位。有效的口服疫苗递送系统必须保护抗原免于粘膜递送时降解,穿透粘膜屏障,并控制抗原以及共刺激和免疫调节剂向特定免疫细胞(即,APC)的释放。在本文中,合成了经marinan修饰的pH响应性P(HEMA-co-MAA)纳米凝胶,并将其评估为口服疫苗的载体。纳米凝胶表现出对pH敏感的特性,在低pH值下捕获并保护装载的货物,并在切换至肠道pH值后触发蛋白质释放。以甘露聚糖作为碳水化合物部分的表面修饰导致巨噬细胞内化作用增强,并增加了相关共刺激分子的表达。这些发现表明甘露聚糖修饰的P(HEMA-co-MAA)纳米凝胶是一种更有效的口服疫苗接种方案的有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号